Imaging of Amyloidβ Aggregation Using a Novel Quantum dot Nanoprobe and its Advanced Applications

Kiyotaka Tokuraku, Tsuneya Ikezu

Research output: Chapter in Book/Report/Conference proceedingChapter


It has been proposed that amyloid β peptide (Aβ) aggregation in the brain plays a major role in the pathogenesis of Alzheimer's disease (AD). Real-time imaging technology for monitoring Aβ aggregation is a valuable approach for understanding the pathogenesis of AD. Quantum dots (QDs), which are fluorescent semiconductor nanocrystals, have evolved over the past decade as highly useful fluorescence probes for bio-nanoimaging due to their specific characteristics, such as nano-scale size, bright emission spectrum, long-term photostability, and multi-wavelength fluorescence emission by a single excitation. We have recently developed QD-labeled Aβ (QDAβ) nanoprobes which enable real-time imaging of Aβ aggregation, including oligomerization and fibrilization in vitro and in an intact cell system. In this chapter, we present the method for the preparation of QDAβ, as well as imaging and quantification of Aβ aggregation in vitro and in cultured cells. Furthermore, we also introduce a high-throughput microscopic drug-screening system for inhibiting Aβ aggregation.

Original languageEnglish (US)
Title of host publicationBio-nanoimaging
Subtitle of host publicationProtein Misfolding and Aggregation
PublisherElsevier Inc.
Number of pages11
ISBN (Print)9780123944313
StatePublished - Nov 2013


  • Aggregation
  • Amyloid
  • Atomic force microscopy
  • Drug screening
  • Fibrilization
  • Fluorescence microscopy
  • Fluorophore
  • Inhibitor
  • Oligomerization
  • Quantum dot
  • Real-time imaging

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Imaging of Amyloidβ Aggregation Using a Novel Quantum dot Nanoprobe and its Advanced Applications'. Together they form a unique fingerprint.

Cite this